127 related articles for article (PubMed ID: 32446873)
21. Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.
Yang H; Chaudhari P; Zhou ZY; Wu EQ; Patel C; Horn DL
Appl Health Econ Health Policy; 2014 Feb; 12(1):85-93. PubMed ID: 24385260
[TBL] [Abstract][Full Text] [Related]
22. Reducing the toxicity of amphotericin B by encapsulation using methoxy poly(ethylene glycol)-b-poly(l-glutamic acid-co-l-phenylalanine).
Yang C; Xue B; Song W; Kan B; Zhang D; Yu H; Shen N; Li X; Tang Z; Chen X
Biomater Sci; 2018 Jul; 6(8):2189-2196. PubMed ID: 29947373
[TBL] [Abstract][Full Text] [Related]
23. Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity.
Gurudevan S; Francis AP; Jayakrishnan A
Eur J Pharm Sci; 2018 Mar; 115():167-174. PubMed ID: 29325755
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D deficiency is a potential risk factor for lipid Amphotericin B nephrotoxicity.
Ferreira D; de Bragança AC; Volpini RA; Shimizu MHM; Gois PHF; Girardi ACC; Seguro AC; Canale D
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007567. PubMed ID: 31295336
[TBL] [Abstract][Full Text] [Related]
25. Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles.
Souza AC; Nascimento AL; de Vasconcelos NM; Jerônimo MS; Siqueira IM; R-Santos L; Cintra DO; Fuscaldi LL; Pires Júnior OR; Titze-de-Almeida R; Borin MF; Báo SN; Martins OP; Cardoso VN; Fernandes SO; Mortari MR; Tedesco AC; Amaral AC; Felipe MS; Bocca AL
Eur J Med Chem; 2015 May; 95():267-76. PubMed ID: 25827397
[TBL] [Abstract][Full Text] [Related]
26. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
27. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
Nimtrakul P; Tiyaboonchai W; Lamlertthon S
Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
[TBL] [Abstract][Full Text] [Related]
28. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
29. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.
Tiphine M; Letscher-Bru V; Herbrecht R
Transpl Infect Dis; 1999 Dec; 1(4):273-83. PubMed ID: 11428998
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
[TBL] [Abstract][Full Text] [Related]
31. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
[TBL] [Abstract][Full Text] [Related]
33. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
[TBL] [Abstract][Full Text] [Related]
34. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
[TBL] [Abstract][Full Text] [Related]
35. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
[TBL] [Abstract][Full Text] [Related]
36. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model.
Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT
Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574
[TBL] [Abstract][Full Text] [Related]
37. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
[TBL] [Abstract][Full Text] [Related]
38. Nephrotoxicity of amphotericin B is attenuated by solubilizing with lipid emulsion.
Dórea EL; Yu L; De Castro I; Campos SB; Ori M; Vaccari EM; Lacaz Cda S; Seguro AC
J Am Soc Nephrol; 1997 Sep; 8(9):1415-22. PubMed ID: 9294833
[TBL] [Abstract][Full Text] [Related]
39. Early detection of amphotericin B induced nephrotoxicity by 99mTc-DTPA: a useful test.
Sawas-Dimopoulou C; Papathanassiou P; Margaritis L
Nucl Med Biol; 1995 Apr; 22(3):297-301. PubMed ID: 7627143
[TBL] [Abstract][Full Text] [Related]
40. Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects.
Leonhard V; Alasino RV; Munoz A; Beltramo DM
Curr Drug Deliv; 2018; 15(6):850-859. PubMed ID: 28925873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
